Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes

Principal Investigator

Stanford Investigator(s)

CONTACT INFORMATION

Primary Contact:
Elizabeth Colbert
(650) 723-3186